Akamara Therapeutics
unknown
unknown
Stage
About
Akamara Therapeutics is a biotechnology company developing supramolecular structures for B-cell immunotherapy, with a lead molecule targeting triple negative breast cancer.
Explore Akamara Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.